Cna Financial Corp Iovance Biotherapeutics, Inc. Transaction History

Cna Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$16.33 - $33.07 $181,850 - $368,267	-11,136 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$28.67 - $52.59 $112,099 - $205,626	3,910 Added 54.11%	11,136 $353,000
Q4 2020 Feb 12, 2021	SELL	$28.04 - $50.26 $93,092 - $166,863	-3,320 Reduced 31.48%	7,226 $335,000
Q3 2020 Nov 12, 2020	SELL	$27.75 - $36.3 $77,977 - $102,002	-2,810 Reduced 21.04%	10,546 $347,000
Q2 2020 Aug 13, 2020	BUY	$27.21 - $41.0 $363,416 - $547,596	13,356 New	13,356 $367,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.